Citius Pharmaceuticals, Inc. 4
4 · Citius Pharmaceuticals, Inc. · Filed Jun 27, 2016
Insider Transaction Report
Form 4
Kane William
Director
Transactions
- Award
Options to Purchase Common Stock
2016-06-23$0.80/sh+200,000$160,000→ 200,000 totalExercise: $0.80Exp: 2026-06-23→ Common Stock (200,000 underlying)
Holdings
- 181,056
Options to Purchase Common Stock
Exercise: $0.00→ Common Stock
Footnotes (2)
- [F1]On March 28, 2014 the Reporting Person was granted a ten-year option to purchase 100,000 shares of LMB common stock at an exercise price of $0.001 per share. The option vests in 1/3 increments over a three year period commencing on the first anniversary of the date of the grant, or March 28, 2015. On March 30, 2015 the Issuer entered into that certain Agreement and Plan of Merger (the "Merger Agreement") by and among the Issuer, Citius LMB Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of the Issuer and Leonard-Meron Biosciences, Inc., a Delaware corporation ("LMB"). Pursuant to the Merger Agreement, the option was converted into an option to purchase 181,056 shares of the Issuer's common stock at a per share exercise price of $0.001. The option vests in 1/3 increments over a three year period with the first installment vesting on March 28, 2015.
- [F2]The options vest in full on the first anniversary of the date of grant.